secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K/A
Filed at:   2022-05-13T23:59:59+00:00
Accession:  0001682852-22-000029
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moderna enters separation agreement with former CFO; includes clawback tied to Dentsply probe
--------------------------------------------------------------------------------

- CFO Jorge Gomez departed May 10; separation agreement signed May 13, 2022.
- Severance of $700K salary (12 months) plus 12 months COBRA premium assistance.
- Company can claw back benefits if Gomez is found to have engaged in wrongdoing or faces fines in Dentsply/SEC investigation.
- Gomez released all claims against Moderna; non-compete waived; other restrictive covenants remain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000168285222000029/0001682852-22-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000168285222000029/mrna-20220510.htm
  HTML page:      https://secwatch.observer/filing/0001682852-22-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer